TrialThe New England journal of medicine2019
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Robert J Motzer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,371 papers cite itlatest 60 shown
this paperpooled ittrialcites it